Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin‐Converting Enzyme Inhibitor or Angiotensin‐Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure

Journal of the American Heart Association - United Kingdom
doi 10.1161/jaha.118.011089
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Transition From Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Ii-Receptor-Blocker to Sacubitril/Valsartan in Chronic Heart Failure Patients: Initial Experiences in Clinical Practice

Cor et Vasa
Cardiovascular MedicineCardiology
2018English

Race and Association of Angiotensin Converting Enzyme/Angiotensin Receptor Blocker Exposure With Outcome in Heart Failure

Journal of Cardiovascular Medicine
MedicineCardiovascular MedicineCardiology
2015English

Effects of Valsartan, an Angiotensin II Receptor Blocker, on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction Who Receive an Angiotensin-Converting Enzyme Inhibitor

Circulation Journal
MedicineCardiovascular MedicineCardiology
2012English

The Significance of Angiotensin Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Use in Sudden Cardiac Death

International Journal of Clinical Medicine
2017English

Factors Associated With Hospitalization of Patients With Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema

Allergy and Asthma Proceedings
MedicineImmunologyPulmonaryAllergyRespiratory Medicine
2013English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Heart Failure With Chronic Kidney Disease ― Propensity Score Matching Analysis ―

Circulation Journal
MedicineCardiovascular MedicineCardiology
2019English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Effect of the Angiotensin Receptor Blocker Valsartan on Morbidity and Mortality in Heart Failure: The Valsartan Heart Failure Trial (Val-HeFT)

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy